Company / PP&E per Share
Ernexa Therapeutics Inc. PP&E per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.03
FY2025
5-year range
$0.02 / $0.98
FY2021-FY2025
Trend
+74.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share returned to growth in FY2025 after 4 years of decline, reaching $0.03.
Based on SEC 10-K filings.
0.03 in FY2025 with a 10-year CAGR of -4.3%.
Declined from $0.10 to $0.03 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -30.8%
- 10-Year CAGR
- -4.3%
Key checks
Key Insights
- In FY2025, pp&e per share increased 74.6% year-over-year.
- Peak pp&e per share was recorded in FY2018.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +74.6% |
| FY2024 | $0.02 | -83.7% |
| FY2023 | $0.10 | -44.4% |
| FY2020 | $0.17 | -82.4% |
| FY2019 | $0.98 | -47.0% |
| FY2018 | $1.85 | +4552.7% |
| FY2017 | $0.04 | -97.6% |
| FY2016 | $1.68 | +3857.0% |
| FY2015 | $0.04 | -2.0% |
| FY2014 | $0.04 | -5.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026